Do histone deacetylase inhibitors have a place in the treatment of myelodysplastic syndromes?

被引：0
|
作者：
Gore, S. D. [1 ]
机构：
[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
来源：
LEUKEMIA RESEARCH | 2007年 / 31卷
关键词：
D O I：
10.1016/S0145-2126(07)70037-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [41] Histone deacetylase inhibitors in the treatment of cancer: overview and perspectives
    Giannini, Giuseppe
    Cabri, Walter
    Fattorusso, Caterina
    Rodriquez, Manuela
    FUTURE MEDICINAL CHEMISTRY, 2012, 4 (11) : 1439 - 1460
  • [42] Potential of histone deacetylase inhibitors for bladder cancer treatment
    Tanji, Nozomu
    Ozawa, Akira
    Kikugawa, Tadahiko
    Miura, Noriyoshi
    Sasaki, Toyokazu
    Azuma, Kouji
    Yokoyama, Masayoshi
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (06) : 959 - 965
  • [43] The potential use of histone deacetylase inhibitors in the treatment of depression
    Fuchikami, Manabu
    Yamamoto, Shigeto
    Morinobu, Shigeru
    Okada, Satoshi
    Yamawaki, Yosuke
    Yamawaki, Shigeto
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2016, 64 : 320 - 324
  • [44] Histone Deacetylase Inhibitors: Novel Agents in Cancer Treatment
    Glass, Erica
    Viale, Pamela Hallquist
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2013, 17 (01) : 34 - 40
  • [45] Histone deacetylase inhibitors providing an epigenetic treatment in cancer
    Cinek, Tugce
    Karali, Nilgun
    ISTANBUL JOURNAL OF PHARMACY, 2021, 51 (02): : 283 - 290
  • [46] Novel histone deacetylase inhibitors in the treatment of thyroid cancer
    Mitsiades, CS
    Poulaki, V
    McMullan, C
    Negri, J
    Fanourakis, G
    Goudopoulou, A
    Richon, VM
    Marks, PA
    Mitsiades, N
    CLINICAL CANCER RESEARCH, 2005, 11 (10) : 3958 - 3965
  • [47] Treatment of chronic kidney diseases with histone deacetylase inhibitors
    Liu, Na
    Zhuang, Shougang
    FRONTIERS IN PHYSIOLOGY, 2015, 6
  • [48] Role of histone deacetylase inhibitors in the treatment of cancer (Review)
    Mei, SP
    Ho, AD
    Mahlknecht, U
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 25 (06) : 1509 - 1519
  • [49] Utility of DNA Methyltransferase Inhibitors for the Treatment of Myelodysplastic Syndromes
    Tohyama, Kaoru
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (22) : 3190 - 3197
  • [50] Do myelodysplastic syndromes with poor marrow really have a better prognosis?
    Lippert, Eric
    HEMATOLOGIE, 2008, 14 (01): : 6 - 7
12345